"We are proud of our 136-year ministry and our commitment to the people of Pueblo, our surrounding communities and our Catholic health ministry."

During the past decade, Saint Mary Corwin Medical Center conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 160 clinical trials were completed, i.e. on average, 116.8% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 71 clinical trials were completed. i.e. 124.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Mary Corwin Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 136 trials, followed by "Alliance for Clinical Trials in Oncology" with 66 trials sponsored, "SWOG Cancer Research Network" with 40 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored and "Eastern Cooperative Oncology Group" with 23 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary Corwin Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 188 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 11 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary Corwin Medical Center" are "Breast Cancer" (26 trials), "Lung Cancer" (13 trials), "Lymphoma" (13 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials) and "Recurrent Breast Carcinoma" (12 trials). Many other conditions were trialed in "Saint Mary Corwin Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Mary Corwin Medical Center" are "Drug" (272 trials), "Other" (169 trials), "Biological" (143 trials), "Procedure" (57 trials) and "Radiation" (45 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (81 trials), "Quality-of-Life Assessment" (56 trials), "Paclitaxel" (36 trials), "Carboplatin" (32 trials) and "Questionnaire Administration" (32 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary Corwin Medical Center" are 262 trials for "All" genders, 53 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Mary Corwin Medical Center". undefined are not yet recruiting, 58 are recruiting, 114 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 130 completed trials in Saint Mary Corwin Medical Center, 2 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary Corwin Medical Center, 6 "Phase 1" clinical trials were conducted, 149 "Phase 2" clinical trials and 172 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".